Literature DB >> 1181152

Leiomyosarcoma of the colon: report of a case and analysis of the relationship of histology to prognosis.

R L Warkel, J B Stewart, A J Temple.   

Abstract

A case of primary leiomyosarcoma of the colon in a patient without gastrointestinal symptomatology who initially manifested a metastasis in the parotid region is described. Review of the literature indicates that mitotic activity is the most reliable histologic criterion for prognosis. Three of five patients with tumors manifesting high mitotic activity succumbed to widespread metastatic disease within four months of initial diagnosis. The prognosis is generally favorable for those patients whose neoplasms have low or moderate mitotic rates.

Entities:  

Mesh:

Year:  1975        PMID: 1181152     DOI: 10.1007/bf02587219

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Liver resection for metastatic colorectal leiomyosarcoma: a single center experience.

Authors:  Walid Faraj; Jessica El-Kehdy; Ghina El Nounou; Samer Deeba; Hawraa Fakih; Mark Jabbour; Ali Haydar; Abdallah Abou El Naaj; Ghassan K Abou-Alfa; Eileen M O'Reilly; Ali Shamseddine; Mohamad Khalife; Deborah Mukherji
Journal:  J Gastrointest Oncol       Date:  2015-10

Review 2.  Leiomyosarcoma of the colon presenting as acute suppurative peritonitis.

Authors:  K Iwasa; K Taniguchi; M Noguchi; H Yamashita; M Kitagawa
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  An unusual case of colonic leiomyosarcoma presenting with fever--significant uptake of radioactivity of gallium-67 in the tumor.

Authors:  A Suzuki; S Fukuda; S Tomita; T Aizawa; A Munakata; Y Yoshida; Y Kamada
Journal:  Gastroenterol Jpn       Date:  1984-10

4.  A pooled analysis of risk factors of surgically treated leiomyosarcoma of the colon in adults.

Authors:  Yun Wang; Hao Wang; Zhi-Lu Yuan; Jing-Fei Zhao; Dian-Bo Dong; Qian Gao
Journal:  World J Surg Oncol       Date:  2020-03-28       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.